Skip to main content
OpenTrials

Clinical trial condition

Moderate or Severe Submental Fullness

Explore clinical trials studying Moderate or Severe Submental Fullness. Study availability and eligibility vary by location and protocol.

12 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Moderate or Severe Submental Fullness trial results

Completed

Evaluate the Efficacy and Safety of Polyene Phosphatidylcholine Injection (AYP-101) for the Reduction of Submental Fat

NCT03982225

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • Yonsei University Health System, Severance Hospital Seoul, South Korea
  • Asan Medical Center Seoul, South Korea
  • Yonsei University Health System, Gangnam Severance Hospital Seoul, South Korea
View Trial Details
Completed

Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area

NCT01426373

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Mark Rubin Beverly Hills, California, United States
  • Mitchel Goldman La Jolla, California, United States
  • Jeffrey Klein San Juan Capistrano, California, United States
  • Ava Shamban Santa Monica, California, United States
View all 18 locations
View Trial Details
Completed

Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

NCT00618722

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Investigational Site Carina Heights, Australia
  • Investigational Site Gold Coast, Australia
  • Investigational Site Toorak, Australia
  • Investigational Site Oakville, Ontario, Canada
View Trial Details
Completed

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

NCT01305577

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Investigational Site Oudenaarde, Minderbroederstaraat, Belgium
  • Investigational Site Arras, France
  • Investigational Site Cannes, France
  • Investigational Site Nice, France
View all 30 locations
View Trial Details
Completed

Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

NCT00618618

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Investigational Site Toorak, Victoria, Australia
  • Investigational Site Sydney, Australia
  • Investigational Site Niagara Falls, Ontario, Canada
  • Investigational Site Oakville, Ontario, Canada
View Trial Details
Completed

Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study

NCT01032889

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Investigational Site Birmingham, Alabama, United States
  • Investigational Site Beverly Hills, California, United States
  • Investigational Site Beverly Hills, California, United States
  • Investigational Site San Francisco, California, United States
View Trial Details
Completed

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

NCT01542034

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Investigational Site Birmingham, Alabama, United States
  • Investigational Site Beverly Hills, California, United States
  • Investigational Site Beverly Hills, California, United States
  • Investigational Site Irvine, California, United States
View all 36 locations
View Trial Details

Related conditions